HCV Elimination, progress to date and what else needs to be done to achieve it | GileadPro

Professor Foster is Professor of Hepatology and a consultant at Barts Health Trust. He trained in Medicine at Oxford and London Universities in the 1980s and completed a PhD in Molecular Biology in 1992. Professor Foster has a 
long-standing interest in the management of chronic viral hepatitis and runs a clinical research program studying the natural history of viral hepatitis, its impact upon patients and their communities, and novel therapies for this disease. He supervises a laboratory research program investigating the basic virology of hepatotropic viruses novel replication models for hepatitis C. He is the editor of The Journal of Viral Hepatitis and has published widely in the field of viral liver disease. He is a past President of BASL, NHSE Clinical Lead for Hepatitis C, Chairman of the NHSE Hepatobiliary Specialised Commissioning Clinical Reference Group.

Dr Kosh Agarwal is a Consultant Hepatologist and Transplant Physician at the Institute of Liver Studies, King’s College Hospital NHS Foundation Trust. He is also lead for the Viral Hepatitis service which is the largest treatment centre for the disease in the UK. He has accreditation in general internal medicine, gastroenterology and hepatology.

His specialist areas of interest and expertise are in the assessment and management of liver disease, specifically viral hepatitis (both hepatitis B and C), hepatocellular cancer (HCC); the optimisation of end-stage liver disease symptoms in the context of assessment for liver transplantation and in pre-and post-transplant management of patients with liver disease.